BGM Group Ltd. (BGM) vs Sofgen Pharma S.A (PROCF)
BGM Group Ltd. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Sofgen Pharma S.A are of similar size ($114.0M and $104.6M). Sofgen Pharma S.A has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 4.0×. Sofgen Pharma S.A has the higher net margin (9.52% vs 1.96%) and the higher return on invested capital (15.2% vs 0.00%). Across the 14 metrics below, Sofgen Pharma S.A leads on 9 and BGM Group Ltd. on 5.
Valuation
Profitability
| Metric | BGM | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 6.54% | 56.16% | 53.94% |
| Operating margin | 0.00% | 17.01% | 0.00% |
| Net margin | 1.96% | 9.52% | 0.00% |
| Free cash flow margin | 0.00% | 17.66% | 0.00% |
| Return on equity | 0.00% | (213.06%) | (0.40%) |
| Return on assets | 0.00% | 8.82% | (3.32%) |
| Return on invested capital | 0.00% | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack